S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q1 2021

Avoro Capital Advisors

Period: Q1 2021 Β· Filed: 2021-05-17
View on SEC EDGAR β†—
AUM
$5.79B
Total portfolio value
Positions
46
Reported securities
Top Holding
HZNP
14.3% $828.4M
QoQ Changes
+7 / -5
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-05-17) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
HZNPHORIZON THERAPEUTICS PLC$828.4M14.31%β€”β€”
14.3%
MRTXMIRATI THERAPEUTICS INC$800.8M13.83%β€”β€”
13.8%
UTHRUNITED THERAPEUTICS CORP$501.8M8.67%$167.27$555.91+232.3%
8.7%
XLRNACCELERON PHARMA INC$406.8M7.03%β€”β€”
7.0%
VRTXVERTEX PHARMACEUTICALS INC$300.9M5.20%$214.89$528.04+145.7%
5.2%
ARNAARENA PHARMACEUTICALS INC$281.0M4.85%β€”β€”
4.8%
ARGXARGENX SE$254.9M4.40%$275.39$939.68+241.2%
4.4%
IOVAIOVANCE BIOTHERAPEUTICS INC$253.3M4.37%$31.66$4.31-86.4%
4.4%
ASCENDIS PHARMA$244.9M4.23%β€”β€”
4.2%
MDGLMADRIGAL PHARMACEUTICALS INC$166.7M2.88%$116.97$528.10+351.5%
2.9%
SRPTSAREPTA THERAPEUTICS INC$160.2M2.77%$74.53$19.28-74.1%
2.8%
BMRNBIOMARIN PHARMACEUTICAL INC$124.6M2.15%$75.51$58.99-21.9%
2.1%
FOLDAMICUS THERAPEUTICS INC$121.0M2.09%β€”β€”
2.1%
KURAKURA ONCOLOGY INC$113.1M1.95%$28.27$11.10-60.7%
1.9%
MRSNMERSANA THERAPEUTICS INC$110.0M1.90%β€”β€”
1.9%
ADVMADVERUM BIOTECHNOLOGIES INC$78.9M1.36%β€”β€”
1.4%
PMVPPMV PHARMACEUTICALS INC$77.6M1.34%$32.89$1.22-96.3%
1.3%
CNSTCONSTELLATION PHARMACEUTICALS INC$69.0M1.19%β€”β€”
1.2%
XENEXENON PHARMACEUTICALS INC$65.3M1.13%$17.90$60.96+240.6%
1.1%
ACADACADIA PHARMACEUTICALS INC$64.5M1.11%$25.80$25.97+0.7%
1.1%
TRILLIUM THERAPEUTICS INC$61.2M1.06%β€”β€”
1.1%
SNDXSYNDAX PHARMACEUTICALS INC$55.9M0.97%$22.36$21.82-2.4%
1.0%
RLMDRELMADA THERAPEUTICS INC$53.7M0.93%$35.21$6.28-82.2%
0.9%
MRNSMARINUS PHARMACEUTICALS INC$50.1M0.86%β€”β€”
0.9%
PRAXPRAXIS PRECISION MEDICINES INC$47.4M0.82%$491.40$318.52-35.2%
0.8%
CBAYCYMABAY THERAPEUTICS INC$46.8M0.81%β€”β€”
0.8%
ISEEIVERIC BIO INC$44.8M0.77%β€”β€”
0.8%
APLSAPELLIS PHARMACEUTICALS INC$42.9M0.74%$42.91β€”
0.7%
DCPHDECIPHERA PHARMACEUTICALS INC$40.0M0.69%β€”β€”
0.7%
DSGNDESIGN THERAPEUTICS INC$39.7M0.69%$29.90$15.64-47.7%
0.7%

Quarter-on-Quarter Activity

Q1 2021 vs. Q4 2020

New Positions (7)

TickerIssuerNotionalSince Filing
VRTXVERTEX PHARMACEUTICALS INC$300.9M+145.7%
ASCENDIS PHARMA$244.9M
APLSAPELLIS PHARMACEUTICALS INC$42.9M
DSGNDESIGN THERAPEUTICS INC$39.7M-47.7%
MRUSMERUS N V$13.9M
JNCEJOUNCE THERAPEUTICS INC$5.7M
LKFTGALAPAGOS NV$0.2M

Exited Positions (5)

TickerIssuerNotional
ASNDASCENDIS PHARMA$300.2M
ITOSITEOS THERAPEUTICS INC$15.6M
CUECUE BIOPHARMA INC$5.7M
ATNXATHENEX INC$4.1M
NKTRNEKTAR THERAPEUTICS$0.0M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SNDXSYNDAX PHARMACEUTICALS INC$45.9M+455.6%-2.4%
MNKDMANNKIND CORP$18.4M+114.3%
XLRNACCELERON PHARMA INC$208.5M+93.5%
FOLDAMICUS THERAPEUTICS INC$-86.8M+36.1%
XENEXENON PHARMACEUTICALS INC$22.3M+30.4%+240.6%
ACADACADIA PHARMACEUTICALS INC$-39.8M+28.2%+0.7%
SRPTSAREPTA THERAPEUTICS INC$-138.1M+22.9%-74.1%
MDGLMADRIGAL PHARMACEUTICALS INC$30.5M+16.3%+351.5%

Trimmed (5)

TickerIssuerNotionalShares Ξ”
DCPHDECIPHERA PHARMACEUTICALS INC$-34.1M-31.3%
BDTXBLACK DIAMOND THERAPEUTICS INC$-9.8M-31.2%
TVTXTRAVERE THERAPEUTICS INC$-17.9M-30.6%
ARNAARENA PHARMACEUTICALS INC$-40.9M-3.3%
TRILLIUM THERAPEUTICS INC$-24.1M-1.7%
← Back to Hedge Funds